# NHS-IL12 for Solid Tumors

> **NCT01417546** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 72 (actual)

## Conditions studied

- Epithelial Neoplasms, Malignant
- Epithelial Tumors, Malignant
- Malignant Mesenchymal Tumor

## Interventions

- **DRUG:** NHS-IL-12

## Key facts

- **NCT ID:** NCT01417546
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-12
- **Primary completion:** 2021-06-02
- **Final completion:** 2021-10-14
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01417546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01417546, "NHS-IL12 for Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01417546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*